Form 4: Quest Diagnostics SVP & General Counsel Michael E. Prevoznik Reports Stock Transactions
SEC Form 4 Filing
Michael E. Prevoznik, SVP & General Counsel of Quest Diagnostics, reports the sale of common stock to cover tax obligations and a sale pursuant to a Rule 10b5-1 plan.
Summary
- Michael E. Prevoznik, a Senior Vice President and General Counsel at Quest Diagnostics, filed a Form 4 detailing changes in beneficial ownership.
- On February 28, 2024, shares of common stock were disposed of to satisfy tax obligations related to vesting restricted share units; 405 shares were sold at $126.36, and 456 shares were sold at $126.36.
- On February 29, 2024, 5,611 shares were sold at $125.88 pursuant to a Rule 10b5-1 sales plan.
- Following these transactions, Prevoznik directly owns 38,478 shares of common stock and indirectly owns 5,541 shares through a 401(k)/SDCP.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports stock transactions by an executive. The sales appear to be for routine tax obligations and pre-planned sales.
Industry Context
Form 4 filings are a routine part of the US market and are required by the SEC to provide transparency into the transactions of company insiders. This allows the public to see if company executives are buying or selling shares of their own company.
Key Dates
| Date | Description |
|---|---|
| 02/28/2024 | Sale of common stock to satisfy tax obligations. |
| 02/29/2024 | Sale of common stock pursuant to Rule 10b5-1 sales plan. |
| 03/01/2024 | Date of signature by Attorney in Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.